Published in J Virol on April 01, 1993
Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol (2006) 2.77
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74
Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol (1997) 1.66
Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J Virol (1999) 1.44
Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J Virol (1997) 1.27
Structure of the reovirus outer capsid and dsRNA-binding protein sigma3 at 1.8 A resolution. EMBO J (2001) 1.25
Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J Virol (1999) 1.24
Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection. J Virol (2003) 1.23
Cleavage susceptibility of reovirus attachment protein sigma1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the sigma1 neck. J Virol (1998) 1.22
Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3. J Virol (2002) 1.17
Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J Virol (1997) 1.16
Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem (2013) 1.15
Addition of exogenous protease facilitates reovirus infection in many restrictive cells. J Virol (2002) 1.13
Requirements for the formation of membrane pores by the reovirus myristoylated micro1N peptide. J Virol (2009) 1.12
A translation-attenuating intraleader open reading frame is selected on coronavirus mRNAs during persistent infection. Proc Natl Acad Sci U S A (1993) 1.07
Rapid cell variation can determine the establishment of a persistent viral infection. Proc Natl Acad Sci U S A (1994) 1.01
From touchdown to transcription: the reovirus cell entry pathway. Curr Top Microbiol Immunol (2010) 1.01
Persistent reovirus infections of L cells select mutations in viral attachment protein sigma1 that alter oligomer stability. J Virol (1996) 0.99
Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J Virol (1998) 0.98
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. J Virol (2011) 0.96
Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3. J Virol (2001) 0.94
Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J Virol (1995) 0.93
Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J Virol (2009) 0.93
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J Virol (1998) 0.91
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. Br J Cancer (2006) 0.90
Impact of host proteases on reovirus infection in the respiratory tract. J Virol (2011) 0.89
Establishment of persistent infection with foot-and-mouth disease virus in BHK-21 cells. Virol J (2011) 0.89
Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein sigma3. J Virol (2006) 0.89
Directional release of reovirus from the apical surface of polarized endothelial cells. MBio (2013) 0.88
Prolonged replication in the mouse central nervous system of reoviruses isolated from persistently infected cell cultures. J Virol (1993) 0.87
Determinants of strain-specific differences in efficiency of reovirus entry. J Virol (2010) 0.86
Molecular determinants of proteolytic disassembly of the reovirus outer capsid. J Biol Chem (2012) 0.85
Discovery of mammalian genes that participate in virus infection. BMC Cell Biol (2004) 0.84
Lipid Membranes Facilitate Conformational Changes Required for Reovirus Cell Entry. J Virol (2015) 0.78
Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice. J Virol (2006) 0.78
A leaderless genome identified during persistent bovine coronavirus infection is associated with attenuation of gene expression. PLoS One (2013) 0.78
Brain- and intestine-specific variants of reovirus serotype 3 strain dearing are selected during chronic infection of severe combined immunodeficient mice. J Virol (1995) 0.76
Lipids Cooperate with the Reovirus Membrane Penetration Peptide to Facilitate Particle Uncoating. J Biol Chem (2016) 0.75
The reovirus μ1 340-343 loop controls entry related conformational changes. J Virol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol (1992) 13.15
Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol (1982) 5.11
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
The nature of the polypeptide encoded by each of the 10 double-stranded RNA segments of reovirus type 3. Virology (1978) 3.61
Inhibitors of lysosomal function. Methods Enzymol (1983) 3.17
Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology (1978) 2.51
Defective acidification of endosomes in Chinese hamster ovary cell mutants "cross-resistant" to toxins and viruses. Proc Natl Acad Sci U S A (1983) 2.39
Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell (1981) 2.23
Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology (1981) 2.20
Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc Natl Acad Sci U S A (1985) 2.15
Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology (1982) 2.08
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host. J Clin Invest (1991) 1.73
A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology (1978) 1.72
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science (1983) 1.50
Role of the S4 gene in the establishment of persistent reovirus infection in L cells. Cell (1982) 1.38
Persistent infections in L cells with temperature-sensitive mutants of reovirus. J Virol (1977) 1.37
Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L-cells. J Virol (1985) 1.31
Reovirus inhibition of cellular DNA synthesis: role of the S1 gene. J Virol (1981) 1.24
Strategies of virus persistence. Br Med Bull (1985) 1.10
Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology (1992) 1.09
Selection of a mutant S1 gene during reovirus persistent infection of L cells: role in maintenance of the persistent state. Virology (1983) 0.97
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
Structure of the reovirus core at 3.6 A resolution. Nature (2000) 4.28
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci U S A (1994) 3.88
Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol (1977) 3.87
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Isolation and preliminary genetic and biochemical characterization of temperature-sensitive mutants of reovirus. Virology (1969) 3.66
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
Intestinal M cells: a pathway for entry of reovirus into the host. Science (1981) 3.23
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother (2006) 2.75
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol (1995) 2.71
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med (1977) 2.53
Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology (1978) 2.51
Host restriction of Friend leukemia virus. Role of the viral outer coat. Proc Natl Acad Sci U S A (1973) 2.44
Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol (1989) 2.38
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Activation and characterization of the reovirus transcriptase: genetic analysis. J Virol (1982) 2.36
Molecular basis of reovirus virulence. Role of the M2 gene. J Exp Med (1980) 2.32
A carboxy-terminal fragment of protein mu 1/mu 1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol (1992) 2.29
Identification of the gene coding for the hemagglutinin of reovirus. Virology (1978) 2.28
Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell (1981) 2.23
Intracellular synthesis of measles virus-specified polypeptides. J Virol (1978) 2.21
Polymorphism of the migration of double-stranded RNA genome segments of reovirus isolates from humans, cattle, and mice. J Virol (1979) 2.15
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Characterization of a zinc blotting technique: evidence that a retroviral gag protein binds zinc. Proc Natl Acad Sci U S A (1988) 2.13
Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (1982) 2.11
Mammalian reoviruses contain a myristoylated structural protein. J Virol (1991) 2.09
Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology (1982) 2.08
Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol (1980) 2.06
Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol (1993) 1.99
Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol Cell Biol (1988) 1.96
Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology (1983) 1.95
Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature (1985) 1.95
The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal. Am J Med (1967) 1.88
A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments. Virology (1978) 1.87
Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol (1982) 1.84
Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science (1983) 1.82
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral RNA. Virology (1972) 1.77
Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature (1982) 1.75
Hemagglutinin of rabies and some other bullet-shaped viruses. Proc Soc Exp Biol Med (1968) 1.74
Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host. J Clin Invest (1991) 1.73
A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology (1978) 1.72
Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol (1990) 1.71
Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A (1982) 1.71
Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A (1985) 1.70
Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology (1994) 1.69
Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J Virol (1990) 1.69
In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins mu1 and sigma3. J Virol (1999) 1.67
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J Virol (1989) 1.64
Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses. Proc Natl Acad Sci U S A (1993) 1.64
The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology (1983) 1.63
Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene (2010) 1.63
Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A (1991) 1.60
Role of the mu 1 protein in reovirus stability and capacity to cause chromium release from host cells. J Virol (1996) 1.58
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol (1990) 1.57
Why the smallpox virus stocks should not be destroyed. Science (1993) 1.56
Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol (1990) 1.56
Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J Virol (1993) 1.55
The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology (1982) 1.55
Temperature-sensitive mutants of reovirus type 3 features of genetic recombination. Virology (1971) 1.53
Genetic manipulation of reovirus--a model for modification of disease. N Engl J Med (1972) 1.53
The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol (1989) 1.52
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol (1979) 1.52
Rotavirus open cores catalyze 5'-capping and methylation of exogenous RNA: evidence that VP3 is a methyltransferase. Virology (1999) 1.51
Crystallization of the reovirus type 3 Dearing core. Crystal packing is determined by the lambda 2 protein. J Mol Biol (1990) 1.51
Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science (1983) 1.50
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood (2001) 1.50
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50
Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol (1997) 1.50
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol (1983) 1.46
Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol (1990) 1.44
Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci U S A (1986) 1.43
Reovirus-specific polypeptides: analysis using discontinuous gel electrophoresis. J Virol (1976) 1.42
Internal/structures containing transcriptase-related proteins in top component particles of mammalian orthoreovirus. Virology (1998) 1.42
Complete nucleotide sequence of the M2 gene segment of reovirus type 3 dearing and analysis of its protein product mu 1. Virology (1988) 1.42
Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J Exp Med (1989) 1.41
Differences between the intracellular polypeptides of measles and subacute sclerosing panencephalitis virus. Nature (1978) 1.41
Role of the S4 gene in the establishment of persistent reovirus infection in L cells. Cell (1982) 1.38